Accufix
West Haven
About Accufix
Accufix develops an FDA-approved toe joint resurfacing system designed to improve the symptoms of toe arthritis. It is used on the metatarsal or phalangeal side of the joint and is offered for the big toe as well as all lessor toes in both feet as it supports patients interested in maintaining an active lifestyle who do not want their joint fixated with plates and screws.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.3M
- Last round: Series Unknown (Oct 2022)
- Website: accufixsurgical.com
- Phone: 8023241558
Industries & Categories
Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/accufix-10080 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.